QuantumLeap works with leading healthcare researchers and providers in making leading edge treatments available to patients. Our strategy is to use a broad partnering model to help expedite treatments and services from research labs into patient care settings.

University of California – San Francisco :: QuantumLeap has a unique agreement with UCSF to act as a technology transfer partner for certain Intellectual Properties developed within UCSF’s Breast Cancer Center. This innovative licensing agreement allows for such research, developed within UCSF, to quickly reach patients to improve their quality of life.
Amgen :: Amgen Corp. has provided a generous donation to QuantumLeap to fund the national rollout of BreastCancertTrials.org, a free website to match breast cancer patients with relevant, leading edge clinical trials.
AstraZeneca :: AstraZeneca Corp. has provided a generous donation to QuantumLeap to fund certain marketing activities to promote and communicate BreastCancerTrials.org.

The Safeway Foundation ::  The Safeway Foundation has provided significant funding to QuantumLeap to fund on-going development and operations of BreastCancerTrials.org.